Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats.
BACKGROUND: The intestinal epithelium is a barrier that composes one of the most immunologically active surfaces of the body due to constant exposure to microorganisms as well as an infinite diversity of food antigens. Disruption of intestinal barrier function and aberrant mucosal immune activation...
Main Authors: | Ricardo Valladares, Dhyana Sankar, Nan Li, Emily Williams, Kin-Kwan Lai, Asmaa Sayed Abdelgeliel, Claudio F Gonzalez, Clive H Wasserfall, Joseph Larkin, Desmond Schatz, Mark A Atkinson, Eric W Triplett, Josef Neu, Graciela L Lorca |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2865539?pdf=render |
Similar Items
-
Identification of Biomarkers for Systemic Distribution of Nanovesicles From Lactobacillus johnsonii N6.2
by: Natalie A. Harrison, et al.
Published: (2021-08-01) -
Lactobacillus johnsonii N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy Adults
by: Guillermo E. Marcial, et al.
Published: (2017-06-01) -
Sex Modulates Lactobacillus johnsonii N6.2 and Phytophenol Effectiveness in Reducing High Fat Diet Induced mTOR Activation in Sprague-Dawley Rats
by: Danielle N. Kling, et al.
Published: (2018-11-01) -
Microencapsulation of Lactobacillus acidophilus and Lactobacillus johnsonii
by: Chia-Wen Kuo, et al.
Published: (2014) -
Use of Lactobacillus johnsonii in broilers challenged with Salmonella sofia
by: Chen G. Olnood, et al.
Published: (2015-09-01)